Literature DB >> 24777605

Interference with ubiquitination in CFTR modifies stability of core glycosylated and cell surface pools.

Seakwoo Lee, Mark J Henderson, Eric Schiffhauer, Jordan Despanie, Katherine Henry, Po Wei Kang, Douglas Walker, Michelle L McClure, Landon Wilson, Eric J Sorscher, Pamela L Zeitlin.   

Abstract

It is recognized that both wild-type and mutant CFTR proteins undergo ubiquitination at multiple lysines in the proteins and in one or more subcellular locations. We hypothesized that ubiquitin is added to specific sites in wild-type CFTR to stabilize it and at other sites to signal for proteolysis. Mass spectrometric analysis of wild-type CFTR identified ubiquitinated lysines 68, 710, 716, 1041, and 1080. We demonstrate that the ubiquitinated K710, K716, and K1041 residues stabilize wild-type CFTR, protecting it from proteolysis. The polyubiquitin linkage is predominantly K63. N-tail mutants, K14R and K68R, lead to increased mature band CCFTR, which can be augmented by proteasomal (but not lysosomal) inhibition, allowing trafficking to the surface. The amount of CFTR in the K1041R mutant was drastically reduced and consisted of bands A/B, suggesting that the site in transmembrane 10 (TM10) was critical to further processing beyond the proteasome. The K1218R mutant increases total and cell surface CFTR, which is further accumulated by proteasomal and lysosomal inhibition. Thus, ubiquitination at residue 1218 may destabilize wild-type CFTR in both the endoplasmic reticulum (ER) and recycling pools. Small molecules targeting the region of residue 1218 to block ubiquitination or to preserving structure at residues 710 to 716 might be protein sparing for some forms of cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777605      PMCID: PMC4097669          DOI: 10.1128/MCB.01042-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Immunocytochemical localization of the cystic fibrosis gene product CFTR.

Authors:  I Crawford; P C Maloney; P L Zeitlin; W B Guggino; S C Hyde; H Turley; K C Gatter; A Harris; C F Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

2.  Ivacaftor in a G551D homozygote with cystic fibrosis.

Authors:  Michael J Harrison; Desmond M Murphy; Barry J Plant
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

3.  Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.

Authors:  Juan L Mendoza; André Schmidt; Qin Li; Emmanuel Nuvaga; Tyler Barrett; Robert J Bridges; Andrew P Feranchak; Chad A Brautigam; Philip J Thomas
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect.

Authors:  Qian Dong; Lynda S Ostedgaard; Christopher Rogers; Daniel W Vermeer; Yuping Zhang; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-30       Impact factor: 11.205

5.  I-TASSER: a unified platform for automated protein structure and function prediction.

Authors:  Ambrish Roy; Alper Kucukural; Yang Zhang
Journal:  Nat Protoc       Date:  2010-03-25       Impact factor: 13.491

6.  Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications.

Authors:  Michelle McClure; Lawrence J DeLucas; Landon Wilson; Marjorie Ray; Steven M Rowe; Xiaoyun Wu; Qun Dai; Jeong S Hong; Eric J Sorscher; John C Kappes; Stephen Barnes
Journal:  Protein Eng Des Sel       Date:  2011-11-25       Impact factor: 1.650

7.  Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.

Authors:  Anita Saxena; Yeshavanth K Banasavadi-Siddegowda; Yifei Fan; Sumit Bhattacharya; Gargi Roy; David R Giovannucci; Raymond A Frizzell; Xiaodong Wang
Journal:  J Biol Chem       Date:  2012-04-13       Impact factor: 5.157

Review 8.  Applications of proteomic technologies for understanding the premature proteolysis of CFTR.

Authors:  Mark J Henderson; Om V Singh; Pamela L Zeitlin
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

9.  A PDZ-interacting domain in CFTR is an apical membrane polarization signal.

Authors:  B D Moyer; J Denton; K H Karlson; D Reynolds; S Wang; J E Mickle; M Milewski; G R Cutting; W B Guggino; M Li; B A Stanton
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

10.  Degradation of CFTR by the ubiquitin-proteasome pathway.

Authors:  C L Ward; S Omura; R R Kopito
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

View more
  11 in total

Review 1.  Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.

Authors:  Michelle L McClure; Stephen Barnes; Jeffrey L Brodsky; Eric J Sorscher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

2.  Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection.

Authors:  James David Londino; Ahmed Lazrak; James W Noah; Saurabh Aggarwal; Vedrana Bali; Bradford A Woodworth; Zsuzsanna Bebok; Sadis Matalon
Journal:  FASEB J       Date:  2015-03-20       Impact factor: 5.191

3.  Mechanisms of Niemann-Pick type C1 Like 1 protein degradation in intestinal epithelial cells.

Authors:  Pooja Malhotra; Vinay Soni; Yoshihide Yamanashi; Tappei Takada; Hiroshi Suzuki; Ravinder K Gill; Seema Saksena; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-21       Impact factor: 4.249

4.  A posttranslational modification code for CFTR maturation is altered in cystic fibrosis.

Authors:  Sandra Pankow; Casimir Bamberger; John R Yates
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

5.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

6.  A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Lianwu Fu; Sadis Matalon; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2015-09-03       Impact factor: 5.191

7.  CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation.

Authors:  Xia Hou; Qingtian Wu; Carthic Rajagopalan; Chunbing Zhang; Mohamad Bouhamdan; Hongguang Wei; Xuequn Chen; Khalequz Zaman; Chunying Li; Xiaonan Sun; Song Chen; Raymond A Frizzell; Fei Sun
Journal:  FASEB J       Date:  2019-08-26       Impact factor: 5.834

8.  Direct interactions between ENaC gamma subunit and ClCN2 in cystic fibrosis epithelial cells.

Authors:  Katherine R Henry; Seakwoo Lee; Douglas Walker; Pamela L Zeitlin
Journal:  Physiol Rep       Date:  2015-01-27

Review 9.  Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.

Authors:  Samuel Estabrooks; Jeffrey L Brodsky
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923

Review 10.  Revisiting CFTR Interactions: Old Partners and New Players.

Authors:  Carlos M Farinha; Martina Gentzsch
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.